Fatigue News and Research

RSS

Targets to improve palliative patients’ wellbeing identified

Pain, depression, drowsiness, fatigue, and appetite loss are the symptoms that most affect the wellbeing of cancer patients being treated palliatively, report Canadian researchers.

16 Aug 2012

Continuous oral contraceptives provide earlier relief for women with dysmenorrhea

Taking oral contraceptives continuously, rather than as traditionally prescribed for each cycle, provides earlier relief for moderate to severe menstrual cramps -- dysmenorrhea -- according to researchers at Penn State College of Medicine.

16 Aug 2012

Heat wave safety tips from Children's Hospital Los Angeles

With July 2012 on record as being one of the hottest months in U.S. history and the August heat showing no let up in many parts of the country, how can parents protect their children's health during a heat wave? "While kids and teens may think of themselves as invincible, they're prone to heat-related illnesses," says Megan Summers, a registered nurse in the Children's Hospital Los Angeles' Rehabilitation Unit.

12 Aug 2012

FDA approved drug to treat Ph- acute lymphoblastic leukemia

The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.

10 Aug 2012

Patients in clinical trials of new targeted cancer therapies appear to have lower risk of side-effects

Patients in early clinical trials of new-style targeted cancer therapies appear to have a much lower risk of the most serious side-effects than with traditional chemotherapy, according to a new analysis.

8 Aug 2012

About half of adults with type 2 diabetes experience acute and chronic pain

Almost half of adults with type 2 diabetes report acute and chronic pain, and close to one quarter report neuropathy, fatigue, depression, sleep disturbance and physical or emotional disability, according to a study of more than 13,000 adults conducted by researchers at the San Francisco VA Medical Center, the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, CA. The researchers also found significant rates of shortness of breath, nausea and constipation.

8 Aug 2012

Common myths about eyes

The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.

7 Aug 2012

High mold count signals dangerous air quality warning in Chicago

Chicago's mold count today is 125,000 plus - more than double the 50,000 threshold that signals a dangerous air quality warning. "Today's mold count is the highest I have recorded in more than 15 years," said Dr. Joseph Leija, who performs the Gottlieb Allergy Count, the official allergy count for the Midwest. "Midwesterners with sensitive respiratory systems will experience itchy throats, runny noses and feel generally rundown."

7 Aug 2012

Sanofi-aventis receives FDA approval for Zaltrap to treat colorectal cancer

The U.S. Food and Drug Administration today approved Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.

6 Aug 2012

UI Hospital implants NeuRx Diaphragm Pacing System in a patient with ALS

The University of Illinois Hospital & Health Sciences System is one of only a dozen hospitals nationwide to implant the NeuRx Diaphragm Pacing System in a patient with amyotrophic lateral sclerosis (ALS).

3 Aug 2012

Researchers develop blue light to help manage internal clocks of night workers

Researchers at Universit- Laval have developed a blue light to help bleary eyed shift workers regulate their internal clocks and get the sleep they need when they need it.

2 Aug 2012

Sickle cell trait link with sudden athlete death ‘confirmed’

Researchers say they have definitively confirmed that there is a link between the sickle cell trait and sudden cardiac death in African–American athletes.

2 Aug 2012

Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner

Breast cancer is the most important cancer for women in the developed world. About 20% of all patients diagnosed with breast cancer die of metastatic disease.

1 Aug 2012

Encouraging results from Tonix TNX-102 SL clinical trial for fibromyalgia syndrome

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, announces that the clinical portion of a human study of a solution version of TNX-102 2.4 mg sublingual tablets has completed.

30 Jul 2012

Viral evolution and host protein levels predict rapid disease progression in hepatitis C patients

Scientists at the National Institutes of Health have identified several factors in people infected with the hepatitis C virus that may predict whether the unusually rapid progression of disease from initial infection to severe liver conditions, such as cirrhosis, will occur. Knowing whether a patient's condition is likely to deteriorate quickly could help physicians decide on the best course of treatment.

27 Jul 2012

Surgical distractions could have disastrous consequences

In a simulated study, the rate of major errors committed while novice surgeons were exposed to typical interruptions and distractions was almost 50%, indicating that such exposure could seriously risk patient safety.

26 Jul 2012

Myotonia less important to patients with myotonic dystrophy than other symptoms

Complex, multi-system diseases like myotonic dystrophy - the most common adult form of muscular dystrophy - require physicians and patients to identify which symptoms impact quality of life and, consequently, what treatments should take priority. However, a new study out this month in the journal Neurology reveals that there is often a disconnect between the two groups over which symptoms are more important, a phenomenon that not only impacts care but also the direction of research into new therapies.

26 Jul 2012

Multi-center clinical trial results demonstrate safety and efficacy of carfilzomib for multiple myeloma

Researchers from John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, played leading roles in three separate multi-center studies with the new proteasome inhibitor carfilzomib published in Blood, a major peer-reviewed scientific journal.

26 Jul 2012

Study uses photodynamic therapy to ablate cardiac myocytes responsible for arrhythmias

University of Michigan heart researchers are shedding light on a safer method for steadying an abnormal heart rhythm that prevents collateral damage to healthy cells.

25 Jul 2012

Top-line results in Pfizer's Lyrica long term safety study for Generalized Anxiety Disorder

Pfizer Inc. announced today that top-line results for Lyrica (pregabalin) capsules Study A0081147 - Long Term Safety and Efficacy of Pregabalin in Subjects with Generalized Anxiety Disorder (GAD) - demonstrate that drug discontinuation symptoms were low after tapering Lyrica treatment following three months and six months in GAD patients.

23 Jul 2012

Fatigue News and Research

Targets to improve palliative patients’ wellbeing identified

Continuous oral contraceptives provide earlier relief for women with dysmenorrhea

Heat wave safety tips from Children's Hospital Los Angeles

FDA approved drug to treat Ph- acute lymphoblastic leukemia

Patients in clinical trials of new targeted cancer therapies appear to have lower risk of side-effects

About half of adults with type 2 diabetes experience acute and chronic pain

Common myths about eyes

High mold count signals dangerous air quality warning in Chicago

Sanofi-aventis receives FDA approval for Zaltrap to treat colorectal cancer

UI Hospital implants NeuRx Diaphragm Pacing System in a patient with ALS

Researchers develop blue light to help manage internal clocks of night workers

Sickle cell trait link with sudden athlete death ‘confirmed’

Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner

Encouraging results from Tonix TNX-102 SL clinical trial for fibromyalgia syndrome

Viral evolution and host protein levels predict rapid disease progression in hepatitis C patients

Surgical distractions could have disastrous consequences

Myotonia less important to patients with myotonic dystrophy than other symptoms

Multi-center clinical trial results demonstrate safety and efficacy of carfilzomib for multiple myeloma

Study uses photodynamic therapy to ablate cardiac myocytes responsible for arrhythmias

Top-line results in Pfizer's Lyrica long term safety study for Generalized Anxiety Disorder

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News